We are live on ! Find out more
CGTX icon

Cognition Therapeutics
CGTX

20 hedge funds and large institutions have $8.44M invested in Cognition Therapeutics in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

6.06% more ownership

Funds ownership: 0% → 6.06% (+6.1%)

Holders
20
Holders Change
+20
Holders Change %
–
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
+$2.94M
2
NCM
Nantahala Capital Management
Connecticut
+$2.04M
3
AFG
American Financial Group
Ohio
+$2M
4
PAWC
P.A.W. Capital
Connecticut
+$975K
5
KAS
Kestra Advisory Services
Texas
+$927K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PM
1
Prosight Management
Texas
$1.91M +$2.94M +301,979 New
NCM
2
Nantahala Capital Management
Connecticut
$1.32M +$2.04M +209,588 New
AFG
3
American Financial Group
Ohio
$1.3M +$2M +205,000 New
PAWC
4
P.A.W. Capital
Connecticut
$632K +$975K +100,000 New
KAS
5
Kestra Advisory Services
Texas
$601K +$927K +95,112 New
Two Sigma Investments
6
Two Sigma Investments
New York
$527K +$813K +83,398 New
Two Sigma Advisers
7
Two Sigma Advisers
New York
$435K +$672K +68,900 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$371K +$571K +58,579 New
Millennium Management
9
Millennium Management
New York
$357K +$550K +56,419 New
BRF
10
B. Riley Financial
California
$195K +$301K +30,904 New
RCG
11
Rock Creek Group
District of Columbia
$167K +$258K +26,439 New
VC
12
Voss Capital
Texas
$167K +$258K +26,439 New
ACM
13
AIGH Capital Management
Maryland
$161K +$249K +25,496 New
AC
14
Apogem Capital
New York
$143K +$221K +22,691 New
Renaissance Technologies
15
Renaissance Technologies
New York
$74K +$115K +11,764 New
BlackRock
16
BlackRock
New York
$51K +$78K +7,997 New
UBS Group
17
UBS Group
Switzerland
$24K +$36.6K +3,749 New
BCA
18
Bray Capital Advisors
Florida
$2K +$2.44K +250 New
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$1K +$975 +100 New
Wells Fargo
20
Wells Fargo
California
– +$234 +24 New

CGTX Hedge Fund Activity: Q4 2021 in Review

20 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q4 2021, worth a combined $8.44M.

Buyers outnumbered sellers: 20 funds opened new CGTX positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Prosight Management, opening a new position worth an estimated $2.94M.

  • 20 institutional investors held Cognition Therapeutics (CGTX) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $8.44M of Cognition Therapeutics stock for Q4 2021.
  • 20 funds opened new Cognition Therapeutics positions in Q4 2021 and 0 closed out, a net change of +20 holders.
  • The largest Cognition Therapeutics buyer in Q4 2021 was Prosight Management, an estimated $2.94M added.

Based on aggregated 13F filings for Q4 2021.